Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)
Clinical trial NCT02596256 · UNKNOWN
Trial details
- NCT number
- NCT02596256
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2019-02-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.